Dianthus Therapeutics DNTH Cash Flow Statement (2017-2025)

NASDAQ DNTH
$108.10 +0.25 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Dianthus Therapeutics Quarterly Cash Flow Statement

Periods 35 quarters
Latest Dec 2025

Dianthus Therapeutics cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 35 quarters of results from Jun 2017 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income
-17.49M-16.93M-17.43M-19.29M-22.95M-17.27M-7.84M-10.05M-7.08M-11.09M-14.73M-10.51M-17.92M-22.21M-25.45M-27.93M-33.01M-31.52M-36.63M
Share-based CompensationStock Comp.
2.19M2.13M3.80M2.18M1.91M1.84M0.66M0.51M7.23M9.41M1.77M0.73M3.10M4.42M4.50M3.92M5.93M6.23M6.35M5.99M
Cash from OperationsCash from Ops.
-16.77M-13.00M-14.07M-15.69M-19.74M-16.85M16.38M-8.85M-10.28M-4.73M-9.99M-11.85M-14.94M-14.53M-21.27M-27.44M-27.63M-23.89M-30.55M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.70M0.40M0.36M0.21M0.33M0.53M0.52M0.42M2.34M2.74M1.90M1.10M2.31M
Depreciation & Amortization (CF)Dep. & Amort.
0.47M0.48M0.53M0.54M0.51M0.48M0.47M0.47M0.42M
Change in Working Capital
Change in ReceivablesChange Receivables
1.00M-0.96M4.96M
Change in Account PayablesChange Payables
-1.65M-0.35M0.12M1.15M1.40M-2.39M0.53M-0.34M-4.73M3.01M0.77M1.60M-2.99M3.25M5.65M2.28M-1.50M3.09M3.00M
Change in Accured ExpensesChange Accured Exp.
-0.58M0.98M0.19M-0.44M-0.86M-0.62M0.94M1.52M-3.34M-1.68M
Investing Activities
Capital ExpendituresCapex
0.01M1.02M0.22M0.01M0.03M0.13M-0.05M0.03M0.01M0.02M0.07M0.01M0.03M0.02M0.03M0.03M0.02M0.05M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
1.51M0.57M
Change in Acquisitions & DivestmentsChange Acquisitions
7.50M30.00M17.50M35.00M2.00M22.00M21.89M15.90M18.00M15.00M8.00M19.00M85.00M82.14M59.60M78.57M
Cash from Investing ActivitiesCash from Investing
7.49M29.89M16.37M-10.32M-40.14M-0.13M-6.88M-12.66M18.13M21.86M-11.51M-8.24M-5.51M1.17M-259.36M-23.11M14.79M26.45M-201.28M
Financing Activities
Other financing activitiesOther financing
0.42M85.98M-0.05M0.01M0.27M0.05M0.30M0.48M0.03M0.57M271.67M
Cash from Financing ActivitiesCash from Financing
0.42M88.86M0.20M0.12M0.05M96.63M138.44M-4.87M217.85M-2.20M0.30M39.68M0.16M0.57M274.51M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
4.51M0.00M0.66M1.40M3.02M1.61M
Net Equity Issued and RepurchasedNet Equity Issued
39.20M0.13M0.19M
Additional items
Change in Cash
-8.86M105.75M2.50M-25.89M-59.88M-16.93M106.12M-21.52M7.85M17.13M116.94M-24.96M197.40M-15.55M-280.33M-10.88M-12.68M3.12M42.68M
Free Cash FlowFCF
-16.78M-14.02M-14.29M-15.71M-19.77M-16.98M16.42M-8.88M-10.30M-4.75M-10.06M-11.86M-14.97M-14.54M-21.29M-27.48M-27.65M-23.94M-30.56M
Net Cash FlowNCF
-8.86M105.75M2.50M-25.89M-59.88M-16.93M106.12M-21.52M7.85M17.13M116.94M-24.96M197.40M-15.55M-280.33M-10.88M-12.68M3.12M42.68M